Diastolic function is a strong predictor of mortality in patients with chronic kidney disease

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Farshid, Ahmad ^a   Pathak, Rajeev ^a   Shadbolt, Bruce ^a,b   Arnolda, Leonard ^a,b   Talaulikar, Girish ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Cardiovascular disease; Chronic kidney disease; Diastolic function; Echocardiography; Troponin T

Indexed keywords

TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SUDDEN DEATH; UNSTABLE ANGINA PECTORIS;

AGED; AUSTRALIAN CAPITAL TERRITORY; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SURVIVAL ANALYSIS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84890597677     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-280     Document Type: Article

References (37)

1. US renal data system 2010 annual data report. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, et al. Am J Kidney Dis 2011 57 1 Suppl 1 8 e1-526 21184928
2. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, et al. Circulation 2003 108 17 2154 2169 10.1161/01.CIR.0000095676.90936.80 14581387 (Pubitemid 37337595)
3. Pathophysiology of cardiovascular disease in hemodialysis patients. Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM, Kidney Int Suppl 2000 76 140 S147 10936811
4. Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it? Dyadyk OI, Bagriy AE, Yarovaya NF, Eur J Heart Fail 1999 1 4 327 336 10.1016/S1388-9842(99)00057-4 10937946 (Pubitemid 30131041)
5. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM, J Am Coll Cardiol 2002 39 4 695 701 10.1016/S0735-1097(01)01781-8 11849871 (Pubitemid 34158168)
6. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE, J Am Soc Nephrol 2003 14 1 159 168 10.1097/01.ASN.0000038685. 95946.83 12506148 (Pubitemid 36032720)
7. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE, J Am Soc Nephrol 2000 11 5 912 916 10770969 (Pubitemid 30241725)
8. Cardiac performance and morphology in end-stage renal disease. Alpert MA, Am J Med Sci 2003 325 4 168 178 10.1097/00000441-200304000-00003 12695722 (Pubitemid 36437990)
9. Echocardiography in chronic kidney disease: diagnostic and prognostic implications. Pecoits-Filho R, Barberato SH, Nephron Clin Pract 2010 114 4 242 c247 10.1159/000276575 20090365
10. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. J Am Soc Echocardiogr 2005 18 12 1440 1463 10.1016/j.echo.2005.10.005 16376782 (Pubitemid 41821197)
11. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A, J Am Soc Echocardiogr 2009 22 2 107 133 10.1016/j.echo.2008.11.023 19187853
12. Universal definition of myocardial infarction. Thygesen K, Alpert JS, White HD, Eur Heart J 2007 28 20 2525 2538 17951287 (Pubitemid 47616190)
13. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, et al. Eur Heart J 2005 26 11 1115 1140 15901669
14. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, et al. N Engl J Med 2009 361 21 2019 2032 10.1056/NEJMoa0907845 19880844
15. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, et al. Lancet 2011 377 9784 2181 2192 10.1016/S0140-6736(11)60739-3 21663949
16. Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, Tangri N, Am J Kidney Dis 2011 57 6 894 902 10.1053/j.ajkd.2010. 12.023 21489668
17. Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). McMurray JJ, Uno H, Jarolim P, Desai AS, de Zeeuw D, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, et al. Am Heart J 2011 16 4 748 755 e743
18. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency Cohort (CRIC) Study. Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, et al. Am J Kidney Dis 2013 62 4 670 678 10.1053/j.ajkd.2013.01.017 23489677
19. Diffuse intermyocardiocytic fibrosis in uraemic patients. Mall G, Huther W, Schneider J, Lundin P, Ritz E, Nephrol Dial Transplant 1990 5 1 39 44 10.1093/ndt/5.1.39 2109283 (Pubitemid 20105635)
20. The heart in renal failure: morphological changes of the myocardium-new insights. Amann K, Ritz E, J Clin Basic Cardiol 2001 4 109 113 (Pubitemid 32825479)
21. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE, J Am Soc Nephrol 1995 5 12 2024 2031 7579050
22. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS, J Am Soc Nephrol 2001 12 12 2768 2774 11729247 (Pubitemid 33115425)
23. B-type natriuretic peptide levels and cardiovascular risk in patients with diastolic dysfunction on chronic haemodialysis: cross-sectional and observational studies. Takase H, Dohi Y, Toriyama T, Okado T, Tanaka S, Shinbo H, Kimura G, Nephrol Dial Transplant 2010 26 2 683 690 20624772
24. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ, Heart 2006 92 6 804 809 16216854 (Pubitemid 43799216)
25. Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease. Rakhit DJ, Zhang XH, Leano R, Armstrong KA, Isbel NM, Marwick TH, Am Heart J 2007 153 4 656 664 10.1016/j.ahj.2007.01.028 17383308 (Pubitemid 46440691)
26. Associations between kidney function and subclinical cardiac abnormalities in CKD. Park M, Hsu C-y, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, et al. J Am Soc Nephrol 2012 23 10 1725 1734 10.1681/ASN.2012020145 22935481
27. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Losi MA, Memoli B, Contaldi C, Barbati G, del Prete M, Betocchi S, Cavallaro M, Carpinella G, Fundaliotis A, Parrella LS, et al. Nephrol Dial Transplant 2010 25 6 1950 1954 10.1093/ndt/gfp747 20075436
28. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A, Circulation 2005 112 20 3088 3096 10.1161/CIRCULATIONAHA. 105.560128 16286604 (Pubitemid 43113440)
29. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. deFilippi CR, Thorn EM, Aggarwal M, Joy A, Christenson RH, Duh SH, Jeudy J, Beache G, Am J Cardiol 2007 100 5 885 889 10.1016/j.amjcard.2007.04.028 17719339 (Pubitemid 47268284)
30. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Ooi DS, Isotalo PA, Veinot JP, Clin Chem 2000 46 3 338 344 10702520 (Pubitemid 30152259)
31. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, Kooman JP, van Dieijen-Visser MP, Ann Clin Biochem 2009 46 Pt 4 283 290 19454537
32. Association of cardiac troponin T with left ventricular structure and function in CKD. Mishra RK, Li Y, DeFilippi C, Fischer MJ, Yang W, Keane M, Chen J, He J, Kallem R, Horwitz EJ, et al. Am J Kidney Dis 2013 61 5 701 709 10.1053/j.ajkd.2012.11.034 23291148
33. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME, J Am Soc Nephrol 2001 12 12 2759 2767 11729246 (Pubitemid 33115424)
34. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U, Am J Kidney Dis 2001 38 2 371 376 10.1053/ajkd.2001.26103 11479164
35. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT, Kidney Int 2005 68 2 818 825 16014061 (Pubitemid 43323139)
36. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Herzog CA, Ma JZ, Collins AJ, Circulation 2002 106 17 2207 2211 10.1161/01.CIR.0000035248.71165.EB 12390949 (Pubitemid 35222214)
37. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Isbel NM, Haluska B, Johnson DW, Beller E, Hawley C, Marwick TH, Am Heart J 2006 151 3 745 753 10.1016/j.ahj.2005.06.017 16504645 (Pubitemid 43290274)